Non-selective HDACs
There are 18 Histone Deacetylase (HDAC) enzymes that are classified into two groups, the histone deacetylase family and the sirtuin family. The histone deacetylase family is divided into classes I, II and IV. Below are a selection of compounds that target two or more classes of HDACs.
Non-selective Histone Deacetylase Inhibitors |
|
---|---|
Cat. No. | 产品名称/活性 |
7981 | Belinostat |
Potent pan-HDAC inhibitor | |
6249 | Givinostat hydrochloride |
Histone deacetylase inhibitor | |
7629 | Panobinostat |
Pan-histone deacetylase inhibitor | |
2682 | Sodium 4-Phenylbutyrate |
Histone deacetylase inhibitor | |
4652 | SAHA |
Class I and II HDAC inhibitor | |
3850 | Sodium butyrate |
Histone deacetylase inhibitor | |
1406 | Trichostatin A |
Potent histone deacetylase inhibitor | |
2815 | Valproic acid, sodium salt |
Histone deacetylase inhibitor |
HDAC classification
Superfamily | Family | Class | Subclass | Protein (human) |
---|---|---|---|---|
Arginase/deacetylase superfamily | Histone deacetylase family | Class I | HDAC1, HDAC2, HDAC3, HDAC8 | |
Class II | Class IIa | HDAC4, HDAC5, HDAC7, HDAC9 | ||
ClassIIb | HDAC6, HDAC10 | |||
Class IV | HDAC11 | |||
Deoxyhypusine synthase like NAD/FAD-binding domain superfamily | Sir2 regulator family | Class III | I | SIRT1, SIRT2, SIRT3 |
II | SIRT4 | |||
III | SIRT5 | |||
IV | SIRT6, SIRT7 |
External sources of pharmacological information for Non-selective HDACs :
Literature for Non-selective HDACs
Tocris offers the following scientific literature for Non-selective HDACs to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Epigenetics Scientific Review
Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.
Rheumatoid Arthritis Poster
Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.